Effects of the selective phosphodiesterase type 5 inhibitor sildenafil citrate on exercise tolerance & vascular function in hypertensive subjects

Project Details

StatusFinished
Effective start/end date1/12/04 → 30/07/07

Funding

  • Non-EU industry, commerce and public corporations: £26,448.00